Aurinia Pharmaceuticals
AUPH
#4681
Rank
A$3.14 B
Marketcap
A$23.67
Share price
-3.25%
Change (1 day)
28.08%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): A$0.24 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are A$0.31 Billion. In 2025 the company made an earning of A$0.16 Billion, an increase over its 2024 earnings that were of A$17.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.24 B43.53%
2025 A$0.16 B864.64%
2024 A$17.45 M-116.44%
2023 -A$0.11 Billion-31.8%
2022 -A$0.16 Billion-39.4%
2021 -A$0.26 Billion61.9%
2020 -A$0.16 Billion-9.73%
2019 -A$0.18 Billion92.65%
2018 -A$91.24 Million36.39%
2017 -A$66.9 Million106.29%
2016 -A$32.43 Million-15.4%
2015 -A$38.33 Million65.84%
2014 -A$23.12 Million129.82%
2013 -A$10.06 Million-26.6%
2012 -A$13.71 Million
2010 -A$7.76 Million-39.22%
2009 -A$12.77 Million-43.78%
2008 -A$22.71 Million-53.19%
2007 -A$48.51 Million42.97%
2006 -A$33.93 Million-23.03%
2005 -A$44.08 Million36.1%
2004 -A$32.39 Million172.57%
2003 -A$11.89 Million484.61%
2002 -A$2.04 Million
2000 -A$9.66 Million453.81%
1999 -A$1.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
A$7.34 B 3,041.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-A$31.45 Million-113.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$7.8 Million-103.34%๐Ÿ‡บ๐Ÿ‡ธ USA